Back

RAS-inhibitors and COVID-19 risk.

29 June 2021 (10:01 - 10:12)
Organised by:
Congress Presentation Part of: COVID-19 and cardiorespiratory failure, from pathophysiology to clinical practice Chronic Heart Failure HFA Premium Access Heart Failure 2021

About the speaker

Photo
Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

3 More presentations in this session

Presentation thumbnail
COVID-19 related heart failure: from systemic infection to cardiac inflammation.
Professor M. Metra (Milan, IT)
Slides Video
Presentation thumbnail
COVID-19 in patients with chronic heart failure: management and prognosis.
Professor Y. Zhang (Beijing, CN)
Slides Video
Presentation thumbnail
COVID-19 and cardiorespiratory failure, from pathophysiology to clinical practice - discussion.
Video

Access the full session

Session thumbnail
COVID-19 and cardiorespiratory failure, from pathophysiology to clinical practice

The Event

Event poster

Heart Failure 2021

29 June 2021 10:01 CET
You may be interested in
thumbnail
Congress Presentation
Preventive anticoagulation.
29 August 2022
thumbnail
Congress Presentation
Previous psychiatric disorders and antipsychotic drugs in COVID-19 patients: early findings on possible worse outcome.
27 August 2021
thumbnail
Congress Presentation
Statin and DAPT use for post-ACS patients during covid-19 pandemic: changing perspectives of Indian practitioners
29 June 2021
thumbnail
Congress Presentation
Comprehensive disease modifying pharmacological therapies improve outcomes in patients with heart failure during the covid-19 pandemic
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources